The company is a medical device company that had developed an apparatus for determining an individuals risk for thrombosis, or adverse blood clot formation can that block blood vessels leading to heart attack or stroke. Currently, a patient’s susceptibility to thrombosis is determined by measuring the individual’s blood clotting time with a prothrombin time test, which is a biochemical method of measuring the amount of time it takes a sample of blood to clot. The company has used it proprietary micro opto-mechanical technology to develop an automated, at-home prothrombin time test device that can determine an individuals clotting time in less than one minute. The company’s methodology provides a faster, more reliable and cost effective means of determining thrombosis risk, particularly with the expansion of medicare coverage that now includes patient self-testing.